Search

for
Search:

Research

5 / 1000+ results

research Implementing patient safety and quality improvement in dermatology. Part 1: Patient safety science

1 citations , February 2022 in “Journal of the American Academy of Dermatology”

The document concludes that improving patient safety and quality is increasingly important in dermatology.

Patient-Reported Outcomes and Safety of Direct-to-Consumer Teledermatology for Finasteride in Male Androgenetic Alopecia

research Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study

January 2023 in “DIGITAL HEALTH”

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

research Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study

April 2026 in “Clinical and Translational Science”

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

research JAAD Game Changers: Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients

August 2023 in “Journal of The American Academy of Dermatology”

Low-dose oral minoxidil is safe for treating hair loss, especially in women, with side effects stopping after use ends.

research Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US

April 2026 in “The Journal of Dermatology”

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

View more "patient safety" in research →

Community Join

5 / 1000+ results

community Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA

in Research/Science 13 upvotes 3 years ago

Kintor Pharma has finished enrolling the first patient in a Phase III trial for KX-826, a treatment for androgenetic alopecia (AGA). One user has set a reminder to check back on the topic in a year.

community Reddit’s Amatorial microneedling meta analysis of 11 different Clinical studies for a Total of 559 patients (Scalp microneedling + topical minoxidil 5%, safety, efficacy and Ideal protocol)

in Microneedling 329 upvotes 4 years ago

Microneedling with 5% minoxidil improves hair growth for hair loss patients. Best protocol: 1.5mm dermaroller weekly for 12 weeks or 0.6mm dermapen every 2 weeks for 12 weeks, skipping topicals for 24 hours.

community Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia

in Research/Science 7 upvotes 5 years ago

Botox injections increase hair density in patients with androgenetic alopecia. Combining Botox with finasteride yields even better results.

community Good news for stem cells hair therapies - US federal judge: using patients' stem cells does NOT fall under FDA jurisdiction

in Research/Science 26 upvotes 3 years ago

A US federal judge ruled that using patients' stem cells for medical treatments is not under FDA jurisdiction, potentially speeding up development of stem cell-based hair loss therapies. Some users are optimistic about increased research and development, while others express skepticism about the ruling's impact on safety and efficacy standards.

community JXL082 is not PP405 and Everychem followed the wrong lead

in Research/Science 43 upvotes 11 months ago

JXL082 is not the same as PP405, leading to a halt in sales and a plan to synthesize the real PP405. There is skepticism about the safety and effectiveness of JXL082 and PP405, with concerns about patent issues and the long-term impact on hair growth.

View more "patient safety" in community →